OPTHEA LIMITED ASX News

14 November 2024

Opthea Received A$15.9 Million R&D Tax Incentive

Opthea receives A$15.9 million for R&D, enhancing cash reserves.

Opthea Biopharmaceuticals R&D Tax Incentive Stock Market News Clinical Trials

Posted on: 14/11/2024

Chair's Address to Shareholders

Opthea reports progress in wet AMD trials and leadership transitions.

Opthea Wet AMD Clinical Trials Biotechnology Leadership Changes

Posted on: 14/11/2024

18 September 2024

Opthea Announces Completion of Drug Substance Campaign

Opthea finalizes drug substance PPQ campaign for sozinibercept.

Opthea Sozinibercept Biopharmaceutical Wet AMD Stock Market News

Posted on: 18/09/2024

31 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Opthea completes pivotal trial enrolment and raises A$227.3m for wet AMD drug development.

Opthea Wet AMD Clinical Trials Biopharmaceutical Stock Market News

Posted on: 31/07/2024